In this issue:
RBANS & subacute cognitive recovery after ICANS with CAR-T therapy
CAR T-cell products for R/R B-ALL
BCMA expression in R/R MM with BCMA CAR-T therapy
The CAR-HT score to guide supportive care after BCMA CAR-T therapy
Real-world safety/efficacy of cilta-cel for R/R MM
Re-admission after BCMA CAR-T therapy in R/R MM
CAR-T therapy vs. historical standard of care in R/R LBCL
Access to CAR-T therapies across G20 countries
Donor-derived anti-CD33 CAR-T therapy for R/R AML after allo-SCT
OR7A10 gain-of-function CAR-NK cells
Please login below to download this issue (PDF)